【摘要】 目的:探究化疗药物引起的骨髓抑制伴粒细胞缺乏性发热患者临床治疗的药学监护。方法:临床药师参与1例乳腺癌患者化疗(环磷酰胺、氟尿嘧啶、表柔比星)后重度骨髓抑制伴粒细胞缺乏性发热的监护过程;从化疗方案的评估、骨髓抑制的对症治疗、抗感染治疗等方面提出药学建议。结果:临床药师参与临床治疗和全过程的药学监护后,患者安全度过化疗后的骨髓抑制期。结论:临床药师的全过程药学监护促进了患者用药的安全性和有效性。更多还原

【Abstract】 Objective: To explore the pharmaceutical care for the clinical medication in patient of granulocyte deficiency fever with myelosuppression caused by chemotherapy drugs. Methods: Clinical pharmacists participated in monitoring of 1 breast cancer patient with severe myelosuppression and granulocytic fever after chemotherapy(cyclophosphamide, fluorouracil, epirubicin). From the evaluation of chemotherapy regimen, symptomatic treatment of myelosuppression and anti-infection medication of pharmaceutical suggestions were put forward. Results: After clinical pharmacists participate in the clinical medication and the whole process of pharmaceutical care, the patient safely passed the myelosuppression period after chemotherapy. Conclusion: The whole-process of pharmaceutical care participated by clinical pharmacists promotes the safety and efficacy of medication for patients.更多还原